Female infertility due to poor ovarian response. Female infertility of other origin
Conditions
Interventions
Intervention 1: First, patients will receive 300 units of Gonal F ampoule and 150 units of human monoposal gonadotropin daily for 4 days from the second day of menstruation. Gonadotropin dose will be
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 45 years Absence of contraindications to the use of indomethacin Normal semen analysis poor ovarian response
Exclusion criteria
Exclusion criteria: Patients with other endocrine disorders such as hyperprolactinemia, PCOS, etc. History of ovarian surgery or ovarian endometrioma Smoker Cardiovascular disorders Receiving drugs affecting the metabolism of indomethacin Unwillingness to cooperate History of peptic ulcer or recurrent active gastric ulcer History of gastrointestinal lesions Allergy to indomethacin or any of the ingredients of this product History of acute attacks of asthma, urticaria, or rhinitis as a result of treatment with aspirin or other non-steroidal anti-inflammatory drugs. Drug abuse History of proctitis or recent rectal bleeding Having nasal polyps with angioneurotic edema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oocyte Quality. Timepoint: 2-3 hrs. after oocyte collection. Method of measurement: Microscopic Evaluation.;Number of retried oocyte. Timepoint: On day of oocyte retrieval. Method of measurement: Counting number of total oocytes with microscope.;Number of embryo. Timepoint: On the 2nd day after ICSI. Method of measurement: Observation with microscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAssociate professor
Bandare-abbas University of Medical Sciences
Outcome results
None listed